Aller au contenu principal
Profil bibliographique

Daniel G. Lloyd

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées
277Citations signalées
0Affiliations récentes

Les domaines associés

Microbial Natural Products and BiosynthesisAntimicrobial Peptides and ActivitiesNatural product bioactivities and synthesisGenomics and Phylogenetic StudiesPlant-Microbe Interactions and Immunity

Les publications récentes

Accès ouvert 2020 article OpenAlex

De Novo Resistance to Arg 10 -Teixobactin Occurs Slowly and Is Costly

Daniel G. Lloyd, Benjamin J. Schofield, Matthew R. Goddard, Edward James Taylor

Bacterial pathogens are rapidly evolving resistance to all clinically available antibiotics. One part of the solution to this complex issue is to better understand the resistance mechanisms to new and existing antibiotics. Here, we focus on two antibiotics. Teixobactin is a recently …

gb, nz (code pays fourni par la source)

16 citations Antimicrobial Agents and Chemotherapy
Accès ouvert 2018 article OpenAlex

Cysteines and Disulfide-Bridged Macrocyclic Mimics of Teixobactin Analogues and Their Antibacterial Activity Evaluation against Methicillin-Resistant Staphylococcus Aureus (MRSA)

Ruba Malkawi, Abhishek Iyer, Anish Parmar, Daniel G. Lloyd et autres

Teixobactin is a highly potent cyclic depsipeptide which kills a broad range of multi-drug resistant, Gram-positive bacteria, such as Methicillin-resistant Staphylococcus aureus (MRSA) without detectable resistance. In this work, we describe the design and rapid synthesis of novel teixobactin analogues containing two …

gb, be, sg (code pays fourni par la source)

16 citations Pharmaceutics
Accès ouvert 2018 article OpenAlex

Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo

Anish Parmar, Rajamani Lakshminarayanan, Abhishek Iyer, Venkatesh Mayandi et autres

The cyclic depsipeptide, teixobactin, kills a number of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and Mycobacterium tuberculosis without detectable resistance. To date, teixobactin is the only molecule in its class that has shown in vivo antibacterial efficacy. In this work, we …

gb, sg, be (code pays fourni par la source)

91 citations Journal of Medicinal Chemistry
Accès ouvert 2017 article OpenAlex

The Myxobacterium Myxococcus xanthus Can Sense and Respond to the Quorum Signals Secreted by Potential Prey Organisms

Daniel G. Lloyd, David E. Whitworth

The myxobacterium Myxococcus xanthus is a predatory member of the soil microfauna, able to consume bacteria (Gram-negative, Gram-positive), archaea and fungi. Many potential prey of M. xanthus communicate amongst themselves using acyl homoserine lactones (AHLs) as quorum signals. M. xanthus cannot itself …

gb (code pays fourni par la source)

60 citations Frontiers in Microbiology
2017 article OpenAlex

Syntheses of potent teixobactin analogues against methicillin-resistant Staphylococcus aureus (MRSA) through the replacement of l -allo-enduracididine with its isosteres

Anish Parmar, Abhishek Iyer, Daniel G. Lloyd, Charlotte S. Vincent et autres

). We can conclude that amino acids which are the closest isosteres of l-allo-enduracididine are the key to synthesising simplified potent analogues of teixobactin using rapid syntheses and improved yields.

in, gb, be (code pays fourni par la source)

38 citations Chemical Communications

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.